Abstract
Background Brain arterial diameters are novel imaging biomarkers of cerebrovascular disease, cognitive decline and dementia. Traditional vascular risk factors have been associated with brain arterial diameters but whether there may be genetic determinants of brain arterial diameters is unknown.
Results We studied 4150 participants from six geographically diverse population-based cohorts (40% European, 14% African, 22% Hispanic, 24% Asian ancestries). We measured brain arterial diameters for 13 segments and averaged them to obtain a global measure of brain arterial diameters as well as the posterior and anterior circulations. A genome-wide association study (GWAS) revealed 14 variants at one locus associated with global brain arterial diameter at genome-wide significance (P<5×10−8) (top SNP, rs7921574; β =0.06, P=1.54×10−8). This locus mapped to an intron of CNNM2. A trans-ancestry GWAS meta-analysis identified two more loci at NT5C2 (rs10748839; P=2.54×10−8) and at AS3MT (rs10786721; P=4.97×10−8), associated with global brain arterial diameter. In addition, two SNPs co-localized with expression of CNNM2 (rs7897654, β=0.12, P=6.17×10−7) and AL356608.1 (rs10786719, β =-0.17, P=6.60×10−6) in brain tissue. For the posterior brain arterial diameter, two variants at one locus mapped to an intron of TCF25 were identified (top SNP, rs35994878; β =0.11, P=2.94×10−8). For the anterior brain arterial diameter, one locus at ADAP1 was identified in trans-ancestry genome-wide association analysis (rs34217249; P=3.11×10−8).
Conclusion Our study reveals three novel risk loci (CNNM2, NT5C2 and AS3MT) associated with brain arterial diameters. Our finding may elucidate the mechanisms by which brain arterial diameters influence the risk of stroke and dementia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This investigation was supported by National Institutes of Health grant R01 AG057709. The Atherosclerosis Risk in Communities (ARIC) Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (75N92022D00001, 75N92022D00002, 75N92022D00003, 75N92022D00004, 75N92022D00005). The ARIC Neurocognitive Study is supported by U01HL096812, U01HL096814, U01HL096899, U01HL096902, and U01HL096917 from the NIH (NHLBI, NINDS, NIA and NIDCD). Funding was also supported by R01AG054491, R01HL087641 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The Northern Manhattan Study (NOMAS) was supported by National Institutes of Health (R01 AG066162, R01 NS36286, R01 NS29993). The Washington Heights Inwood Columbia Aging Project (WHICAP) was supported by National Institutes of Health (R01 AG072474, R01 AG037212, RF1 AG054023). The Epidemiology of Dementia In Singapore (EIDS) study was supported by the National Medical Research Council, Singapore (NMRC/CG/NUHS/2010 [Grant no: R184006184511]). The Memory Clinic in Singapore (MCS) was supported by U01 AG052409. The Framingham Heart Study (FHS) was supported by National Heart, Lung and Blood Institute contracts (N01 HC25195, HHSN268201500001I, 75N92019D00031) with additional support from National Institutes of Health grants (R01 AG047645, R01 HL131029) and an American Heart Association Award (15GPSGC24800006).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The included studies have been approved by local ethics committees: Atherosclerosis Risk in Communities (ARIC) study: The institutional review board at The Johns Hopkins University, Wake Forest University, University of Mississippi Medical Center, and University of Minnesota; The Northern Manhattan Study (NOMAS): The institutional review boards at Columbia University Medical Center and the University of Miami; Washington Heights-Inwood Columbia Aging Project (WHICAP): The institutional review boards at Columbia University Medical Center; Epidemiology of Dementia In Singapore (EDIS): The institutional review boards at Singapore Eye Research Institute; Memory Clinic in Singapore (MCS): The institutional review boards at National University Hospital; Framingham Heart Study (FHS): The institutional review boards at Boston Medical Center.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Contact author: Jose Gutierrez, MD, MPH., Address: 710 W 168th Street, 6th floor, Suite 639, New York, NY, 10032., Email: jg3233{at}cumc.columbia.edu, Phone: (212) 305-1710; Fax: (212) 305-165
Minghua Liu ml3883{at}cumc.columbia.edu, Farid Khasiyev farid.khasiyev{at}health.slu.edu, Sanjeev Sariya ss5505{at}cumc.columbia.edu, Antonio Spagnolo-Allende ajs2363{at}cumc.columbia.edu, Danurys L Sanchez dls167{at}cumc.columbia.edu, Howard Andrews Howard.Andrews{at}nyspi.columbia.edu, Qiong Yang qyang{at}bu.edu, Alexa Beiser alexab{at}bu.edu, Ye Qiao yqiao4{at}jhmi.edu, Emy A Thomas Emy.Anu.Thomas{at}uth.tmc.edu, Jose Rafael Romero joromero{at}bu.edu, Tatjana Rundek TRundek{at}med.miami.edu, Adam M Brickman amb2139{at}cumc.columbia.edu, Jennifer J Manly jjm71{at}cumc.columbia.edu, Mitchell SV Elkind mse13{at}cumc.columbia.edu, Sudha Seshadri seshadri{at}uthscsa.edu, Christopher Chen phccclh{at}nus.edu.sg, Ralph L Sacco rsacco{at}med.miami.edu, Saima Hilal saimahilal{at}nus.edu.sg, Bruce A Wasserman BWasser{at}som.umaryland.edu, Giuseppe Tosto gt2260{at}cumc.columbia.edu, Myriam Fornage Myriam.Fornage{at}uth.tmc.edu, Jose Gutierrez jg3233{at}cumc.columbia.edu
Author name updated
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
